Diamyd Medical AB (publ) announced earnings results for the first quarter ended November 30, 2017. For the quarter, the company reported net income of SEK 586,000 compared to SEK 438,000 a year ago. Total operating income was SEK 655,000 compared to SEK 452,000 a year ago. Operating loss was SEK 10,824,000 compared to SEK 4,445,000 a year ago. Loss before taxes was SEK 10,770,000 compared to SEK 4,336,000 a year ago. Net loss for the period was SEK 11,770,000 compared to SEK 4,336,000 a year ago. Net cash outflow from operating activities was SEK 12,141,000 compared to SEK 4,653,000 a year ago. Loss per share, before and after dilution was SEK 0.2 compared to SEK 0.1 a year ago. Cash outflow per share, before and after dilution was SEK 0.2.